Bildkälla: Stockfoto

Lipigon: Safety Demonstrated in the SAD Part with Lipisense - Redeye

Redeye comments on Lipigon's third quarter report, in particular on the SAD and recently initiated MAD part of the phase I trial with Lipisense and on the financial situation.

Redeye comments on Lipigon's third quarter report, in particular on the SAD and recently initiated MAD part of the phase I trial with Lipisense and on the financial situation.
Börsvärldens nyhetsbrev
ANNONSER